Changes in blood viscosity by heparin and argatroban

Thrombosis Research

Volumn 104, Issue 5, 2001, Pages 371-374

  Hitosugi, Masahito ^a   Niwa, Munehiro ^b   Takatsu, Akihiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY OF COMMERCE   (Japan)

Author keywords

Antithrombotic agents; Blood viscosity; Rheology

Indexed keywords

ANTITHROMBOCYTIC AGENT; ARGATROBAN; HEPARIN DERIVATIVE;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; BLOOD VISCOSITY; CLINICAL TRIAL; CONCENTRATION RESPONSE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK; THROMBIN TIME; THROMBOEMBOLISM; VISCOMETER; VOLUNTEER;

ADULT; ANTICOAGULANTS; BLOOD VISCOSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN; HUMANS; MALE; PIPECOLIC ACIDS;

EID: 0035606338     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00359-0     Document Type: Article

References (17)

1. Venous thrombogenesis
2. Oral thrombin inhibitors: Challenge and progress
3. Antithrombin agents as anticoagulants and antithrombotics: Implications in drug development
4. Rheologic changes in venous blood during prolonged sitting
5. Oral anticoagulant drugs
6. Phase one study of synthetic antithrombin agent (MD-805) single and multiple administration studies
7. Synthetic selective inhibitors of thrombin
8. Coronary thrombosis, effects of blood flow on the mechanism of thrombus formation
9. Hirudin, heparin and placebo during deep arterial injury in the pig
10. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina, a meta-analysis
11. Reactivation of unstable angina after the discontinuation of heparin
12. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
13. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction
14. Characteristics of share-induced aggregation in whole blood
15. High blood viscosity, an aetiological factor in venous thrombosis
16. Clinical significance of blood viscosity
17. The elimination from plasma of intravenous heparin, an experimental study on dogs and humans